We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$54.4B
AUM Growth
+$4.48B
Cap. Flow
+$2.1B
Cap. Flow %
3.86%
Top 10 Hldgs %
19.38%
Holding
3,633
New
237
Increased
1,748
Reduced
1,306
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 9.06%
3 Healthcare 7.76%
4 Industrials 6.89%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHX
3326
DELISTED
Athersys, Inc. Common Stock
ATHX
$19K ﹤0.01%
417
-200
-32% -$9.68K
GEN
3327
DELISTED
Genesis Healthcare, Inc.
GEN
$19K ﹤0.01%
25,000
SDR
3328
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$19K ﹤0.01%
22,793
+6,057
+36% +$7.22K
CANF
3329
Can-Fite BioPharma American Depositary Shares
CANF
$7.37M
$18K ﹤0.01%
4
PM icon
3330
CALL
Philip Morris
PM
$295B
$18K ﹤0.01%
26,500
+500
+2% +$53.3K
XOM icon
3331
CALL
ExxonMobil
XOM
$634B
$18K ﹤0.01%
48,800
+22,200
+83% +$1.84M
CYTR
3332
DELISTED
CytRx Corp
CYTR
$18K ﹤0.01%
10,379
+830
+9% +$1.72K
BIOC
3333
DELISTED
Biocept, Inc.
BIOC
$17K ﹤0.01%
3
KBE icon
3334
CALL
State Street SPDR S&P Bank ETF
KBE
$1.66B
$16K ﹤0.01%
15,000
-600
-4% -$27.6K
MVIS icon
3335
Microvision
MVIS
$78.9M
$16K ﹤0.01%
668
-167
-20% -$4.82K
ABT icon
3336
CALL
Abbott
ABT
$187B
$15K ﹤0.01%
28,100
-34,200
-55% -$1.9M
COOP
3337
DELISTED
Mr. Cooper
COOP
$15K ﹤0.01%
1,428
-663
-32% -$6.37K
KGC icon
3338
CALL
Kinross Gold
KGC
$32.8B
$15K ﹤0.01%
109,500
+27,300
+33% +$114K
JONE
3339
DELISTED
Jones Energy, Inc.
JONE
$15K ﹤0.01%
675
-250
-27% -$5.84K
BX icon
3340
PUT
Blackstone
BX
$110B
$14K ﹤0.01%
51,000
-3,000
-6% -$97.7K
KLAC icon
3341
CALL
KLA
KLAC
$259B
$14K ﹤0.01%
+129,000
New +$1.36M
TECK icon
3342
CALL
Teck Resources
TECK
$32.6B
$14K ﹤0.01%
13,000
-21,100
-62% -$481K
VWO icon
3343
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$14K ﹤0.01%
23,100
ESNC
3344
DELISTED
EnSync Inc
ESNC
$14K ﹤0.01%
36,000
FNSR
3345
CALL
DELISTED
Finisar Corp
FNSR
$14K ﹤0.01%
24,100
-7,900
-25% -$164K
VIAB
3346
CALL
DELISTED
Viacom Inc. Class B
VIAB
$13K ﹤0.01%
+65,500
New +$1.78M
NXEOW
3347
DELISTED
Nexeo Solutions, Inc. Warrant
NXEOW
$13K ﹤0.01%
21,065
GDX icon
3348
PUT
VanEck Gold Miners ETF
GDX
$27.4B
$12K ﹤0.01%
+52,200
New +$1.19M
CGRN
3349
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$12K ﹤0.01%
1,554
+495
+47% +$4.41K
WPRT
3350
PUT
Westport Fuel Systems
WPRT
$35.7M
$11K ﹤0.01%
4,800

Similar funds

Raymond James & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James & Associates held 3,633 positions worth $54.4B, up 9% from $49.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Raymond James & Associates deployed $2.1B of net new capital in Q4 2017, opening 237 new positions and adding to 1,748 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $124M trimmed.

  • Raymond James & Associates's largest Q4 2017 buy was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q4 2017, an estimated $516M increase.
  • Raymond James & Associates's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $124M.
  • Raymond James & Associates fully exited ABM Industries in Q4 2017, selling an estimated $3.17M.
  • Raymond James & Associates's ten largest holdings make up 19% of its $54.4B portfolio in Q4 2017.
  • Raymond James & Associates opened 237 new positions and closed 214 in Q4 2017.
  • Raymond James & Associates's portfolio value rose 9% quarter-over-quarter to $54.4B.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.